American Medical Systems Holdings AMMD
-
Endo's Fourth Quarter Outperforms, but 2012 Outlook Falls Short
… 142 million and $52 million, respectively, to Endo's top line, driven by the firm's purchase of American Medical Systems and HealthTronics. Total revenues during fourth quarter were $803 million, a 57% increase over fourth …
-
New Morningstar Analyst Report - Endo Pharmaceutical Holdings, Inc.
… another urology firm and a generics company to its operations in 2010, and recently made an offer to acquire American Medical Systems to add scale to its devices and service lineup. Although it remains to be seen whether Endo can successfully …
-
Pain Products and Acquisitions Boost Endo's Third Quarter
… Similarly, devices and services sales increased 259% to $186 million thanks to the Endo's purchase of American Medical Systems earlier this year. Adjusted diluted earnings per share increased 45% to $1.25 from $0.86 in third …
-
Endo Pharmaceuticals Holdings CEO Discusses Q2 2011 Results - Earnings Call Transcript
… Holveck – President and CEO Alan Levin – EVP and CFO Julie McHugh – COO Tony Bihl – Group President, American Medical Systems , Inc. Ivan Gergel – EVP, Research & Development Analysts Marc Goodman – UBS Annabel Samimy – Stifel …
-
Core Business Lines Drive Solid Organic Growth for Endo in 2Q
… lifted its full-year outlook based on the timing of the American Medical Systems acquisition (completed in June) and strength in the ..... 8 million from the firm's recent acquisition of American Medical Systems . This represents a highly profitable segment for the …
-
Endo Pharmaceutical Holdings, Inc. ENDP Q2 2011 Earnings Call Transcript
… Officer; Dr. Ivan Gergel, Executive Vice President of RnD; Alan Levin, Executive Vice President and Chief Financial Officer; as well as Tony Bihl, Group President from American Medical Systems . Click here for the full transcript.
-
New Credit Rating: Endo Pharmaceuticals
… rating reflects the specialty pharmaceutical firm's much higher financial leverage after the $2.9 billion American Medical Systems (AMS) acquisition and Endo's ongoing dependence on Lidoderm, which contributes to its negative moat trend …
-
TEXT-S&P ASSIGNS 'BBB-' Rtg to Endo Pharmaceuticals Cred Fac
June 21, 2001--Chadds Ford, Pa.-based specialty pharmaceutical company Endo Pharmaceuticals Holdings Inc. has acquired American Medical Systems Inc. (AMS) for approximately $2.9 billion. Endo...
-
New Morningstar Analyst Report - American Medical Systems Holdings , Inc.
… necessary to improve this product line's profitability. American Medical Systems produces implantable devices and surgical systems for ..... suit as they try to keep health costs under control. American Medical Systems has built a narrow economic moat for its core businesses …
-
Platform and Specialty Pharmaceutical Companies Could Strengthen in Face of Big Pharma's Patent Cliff
… JNJ ) with Synthes; Sanofi ( SNY ) with Genzyme; Valeant ( VRX ) with Biovail; and Endo ( ENDP ) with American Medical Systems . The average multiple for these transactions was four times annual sales. This lofty multple was reaffirmed …